Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

The association between erosive toothwear and gastro-oesophageal reflux-related symptoms and disease: A systematic review and meta-analysis.

Jordão HWT, Coleman HG, Kunzmann AT, McKenna G.

J Dent. 2020 Jan 29:103284. doi: 10.1016/j.jdent.2020.103284. [Epub ahead of print] Review.

PMID:
32006670
2.

Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis.

Gethings-Behncke C, Coleman HG, Jordao HWT, Longley DB, Crawford N, Murray LJ, Kunzmann AT.

Cancer Epidemiol Biomarkers Prev. 2020 Jan 8. doi: 10.1158/1055-9965.EPI-18-1295. [Epub ahead of print] Review.

PMID:
31915144
3.

Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology.

van der Wel MJ, Coleman HG, Bergman JJGHM, Jansen M, Meijer SL; BOLERO working group.

Gut. 2019 Dec 18. pii: gutjnl-2019-318985. doi: 10.1136/gutjnl-2019-318985. [Epub ahead of print]

PMID:
31852770
4.

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study.

McCain RS, McManus DT, McQuaid S, James JA, Salto-Tellez M, Reid NB, Craig S, Chisambo C, Bingham V, McCarron E, Parkes E, Turkington RC, Coleman HG.

Cancer Causes Control. 2020 Jan;31(1):1-11. doi: 10.1007/s10552-019-01247-2. Epub 2019 Nov 30.

5.

The association between self-reported poor oral health and gastrointestinal cancer risk in the UK Biobank: A large prospective cohort study.

Jordão HW, McKenna G, McMenamin ÚC, Kunzmann AT, Murray LJ, Coleman HG.

United European Gastroenterol J. 2019 Nov;7(9):1241-1249. doi: 10.1177/2050640619858043. Epub 2019 Jun 8.

6.

Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.

Liu P, McMenamin ÚC, Spence AD, Johnston BT, Coleman HG, Cardwell CR.

BMC Cancer. 2019 Oct 29;19(1):1017. doi: 10.1186/s12885-019-6242-8.

7.

Colorectal cancer screening: surely FIT for us too.

McFerran E, Kee F, Coleman HG.

Frontline Gastroenterol. 2019 Oct;10(4):445-446. doi: 10.1136/flgastro-2018-101125. Epub 2019 Jan 24. No abstract available.

PMID:
31656576
8.

Prognosis following surgical resection versus local excision of stage pT1 colorectal cancer: A population-based cohort study.

McBride R, Hicks BM, Coleman HG, Loughrey MB, Gavin AT, Dunne PD, Campbell WJ.

Surgeon. 2019 Aug 8. pii: S1479-666X(19)30084-8. doi: 10.1016/j.surge.2019.06.004. [Epub ahead of print]

PMID:
31402122
9.

Statin use and risk of liver cancer: Evidence from two population-based studies.

Tran KT, McMenamin ÚC, Coleman HG, Cardwell CR, Murchie P, Iversen L, Lee AJ, Thrift AP.

Int J Cancer. 2020 Mar 1;146(5):1250-1260. doi: 10.1002/ijc.32426. Epub 2019 Jun 4.

PMID:
31112291
10.

Serum Biomarkers of Iron Status and Risk of Primary Liver Cancer: A Systematic Review and Meta-Analysis.

Tran KT, Coleman HG, McCain RS, Cardwell CR.

Nutr Cancer. 2019;71(8):1365-1373. doi: 10.1080/01635581.2019.1609053. Epub 2019 May 2.

PMID:
31044614
11.

Coffee consumption by type and risk of digestive cancer: a large prospective cohort study.

Tran KT, Coleman HG, McMenamin ÚC, Cardwell CR.

Br J Cancer. 2019 May;120(11):1059-1066. doi: 10.1038/s41416-019-0465-y. Epub 2019 May 1.

PMID:
31040384
12.

External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia.

Kunzmann AT, Thrift AP, Johnston BT, McManus DT, Gavin AT, Turkington RC, Coleman HG.

Aliment Pharmacol Ther. 2019 May;49(10):1274-1281. doi: 10.1111/apt.15235. Epub 2019 Apr 4.

PMID:
30950101
13.

Diagnostic utility of microsurgical carbon dioxide laser excision of oral potentially malignant lesions vs incisional biopsy: a retrospective histopathological review.

Vu J, Coleman HG, Palme CE, Riffat F, Schifter M, Zoellner H.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jun;127(6):516-525. doi: 10.1016/j.oooo.2018.12.010. Epub 2018 Dec 14. Review.

PMID:
30948343
14.

Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.

McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS.

World J Gastroenterol. 2018 Nov 21;24(43):4846-4861. doi: 10.3748/wjg.v24.i43.4846. Review.

15.

Statin use and survival in patients with gastric cancer in two independent population-based cohorts.

Spence AD, Busby J, Hughes CM, Johnston BT, Coleman HG, Cardwell CR.

Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):460-470. doi: 10.1002/pds.4688. Epub 2018 Nov 20.

PMID:
30456916
16.

Sex hormone receptor expression and survival in esophageal adenocarcinoma: a prospective cohort study.

McMenamin ÚC, Trainor J, Coleman HG, McManus DT, McQuaid S, Bingham V, James J, Salto-Tellez M, Johnston BT, Turkington RC.

Oncotarget. 2018 Oct 19;9(82):35300-35312. doi: 10.18632/oncotarget.26236. eCollection 2018 Oct 19.

17.

High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study.

Spence AD, Trainor J, McMenamin Ú, Turkington RC, McQuaid S, Bingham V, James J, Salto-Tellez M, McManus DT, Johnston BT, Cardwell CR, Coleman HG.

Histopathology. 2019 Mar;74(4):587-596. doi: 10.1111/his.13786. Epub 2019 Jan 25.

PMID:
30408225
18.

Punctate MLH1 mismatch repair immunostaining in colorectal cancer.

Loughrey MB, Dunne PD, Coleman HG, McQuaid S, James JA.

Histopathology. 2019 Apr;74(5):795-797. doi: 10.1111/his.13780. Epub 2019 Feb 17. No abstract available.

PMID:
30379344
19.

Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study.

McCain S, Trainor J, McManus DT, McMenamin ÚC, McQuaid S, Bingham V, James JA, Salto-Tellez M, Turkington RC, Coleman HG.

Oncotarget. 2018 Sep 28;9(76):34347-34356. doi: 10.18632/oncotarget.26151. eCollection 2018 Sep 28.

20.

Physical activity, sedentary behaviour and risk of oesophago-gastric cancer: A prospective cohort study within UK Biobank.

Kunzmann AT, Mallon KP, Hunter RF, Cardwell CR, McMenamin ÚC, Spence AD, Coleman HG.

United European Gastroenterol J. 2018 Oct;6(8):1144-1154. doi: 10.1177/2050640618783558. Epub 2018 Jun 7.

21.

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.

Kunzmann AT, Cañadas Garre M, Thrift AP, McMenamin ÚC, Johnston BT, Cardwell CR, Anderson LA, Spence AD, Lagergren J, Xie SH, Smyth LJ, McKnight AJ, Coleman HG.

Gastroenterology. 2019 Jan;156(1):43-45. doi: 10.1053/j.gastro.2018.09.038. Epub 2018 Sep 19.

PMID:
30243622
22.

Current practices and future prospects for the management of gallbladder polyps: A topical review.

McCain RS, Diamond A, Jones C, Coleman HG.

World J Gastroenterol. 2018 Jul 14;24(26):2844-2852. doi: 10.3748/wjg.v24.i26.2844. Review.

23.

The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study.

Kunzmann AT, Coleman HG, Huang WY, Berndt SI.

PLoS Med. 2018 Jun 19;15(6):e1002585. doi: 10.1371/journal.pmed.1002585. eCollection 2018 Jun.

24.

'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study.

van Putten M, Johnston BT, Murray LJ, Gavin AT, McManus DT, Bhat S, Turkington RC, Coleman HG.

United European Gastroenterol J. 2018 May;6(4):519-528. doi: 10.1177/2050640617737466. Epub 2017 Oct 11.

25.

Microscopic colitis: a population-based case series over a 9-year period in Northern Ireland.

Moore M, Coleman HG, Allen PB, Loughrey MB.

Colorectal Dis. 2018 Nov;20(11):1020-1027. doi: 10.1111/codi.14247. Epub 2018 Jun 7.

PMID:
29742325
26.

Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.

Tran KT, McMenamin ÚC, Hicks B, Murchie P, Thrift AP, Coleman HG, Iversen L, Johnston BT, Lee AJ, Cardwell CR.

Aliment Pharmacol Ther. 2018 Jul;48(1):55-64. doi: 10.1111/apt.14796. Epub 2018 May 9.

27.

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma.

Blayney JK, Cairns L, Li G, McCabe N, Stevenson L, Peters CJ, Reid NB, Spence VJ, Chisambo C, McManus D, James J, McQuaid S, Craig S, Arthur K, McArt D, Ong CJ, Lao-Sirieix P, Hamilton P, Salto-Tellez M, Eatock M, Coleman HG, Fitzgerald RC, Kennedy RD, Turkington RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group.

Oncotarget. 2018 Apr 6;9(26):18518-18528. doi: 10.18632/oncotarget.24906. eCollection 2018 Apr 6.

28.

Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis.

Loughrey MB, Bankhead P, Coleman HG, Hagan RS, Craig S, McCorry AMB, Gray RT, McQuaid S, Dunne PD, Hamilton PW, James JA, Salto-Tellez M.

Histopathology. 2018 Aug;73(2):327-338. doi: 10.1111/his.13516. Epub 2018 May 21.

PMID:
29575153
29.

Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer.

Dunne PD, Coleman HG, Bankhead P, Alderdice M, Gray RT, McQuaid S, Bingham V, Loughrey MB, James JA, McCorry AMB, Gilmore A, Holohan C, Klingbiel D, Tejpar S, Johnston PG, McArt DG, Di Nicolantonio F, Longley DB, Lawler M.

Oncotarget. 2018 Feb 13;9(17):13834-13847. doi: 10.18632/oncotarget.24481. eCollection 2018 Mar 2.

30.

Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.

Kunzmann AT, Thrift AP, Cardwell CR, Lagergren J, Xie S, Johnston BT, Anderson LA, Busby J, McMenamin ÚC, Spence AD, Coleman HG.

Clin Gastroenterol Hepatol. 2018 Aug;16(8):1229-1236.e4. doi: 10.1016/j.cgh.2018.03.014. Epub 2018 Mar 17.

PMID:
29559360
31.

Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study.

Gray RT, Coleman HG, Hughes C, Murray LJ, Cardwell CR.

BMC Cancer. 2018 Feb 27;18(1):228. doi: 10.1186/s12885-018-4142-y.

32.

Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.

Spence AD, Busby J, Murchie P, Kunzmann AT, McMenamin ÚC, Coleman HG, Johnston BT, O'Rorke MA, Murray LJ, Iversen L, Lee AJ, Cardwell CR.

Int J Cancer. 2018 Jul 1;143(1):22-31. doi: 10.1002/ijc.31293. Epub 2018 Mar 8.

33.

The association between MAD2 and prognosis in cancer: a systematic review and meta-analyses.

Byrne T, Coleman HG, Cooper JA, McCluggage WG, McCann A, Furlong F.

Oncotarget. 2017 Jun 8;8(60):102223-102234. doi: 10.18632/oncotarget.18414. eCollection 2017 Nov 24.

34.

Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review.

Spence AD, Cardwell CR, McMenamin ÚC, Hicks BM, Johnston BT, Murray LJ, Coleman HG.

BMC Gastroenterol. 2017 Dec 11;17(1):157. doi: 10.1186/s12876-017-0708-4. Review.

35.

Neville Wran's voice: how the Premier's Teflon-coated vocal cords came unstuck.

Tseros E, Riffat F, Palme CE, Coleman HG, Singh NP.

Med J Aust. 2017 Dec 11;207(11):468-470. No abstract available.

PMID:
29227762
36.

QuPath: Open source software for digital pathology image analysis.

Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG, James JA, Salto-Tellez M, Hamilton PW.

Sci Rep. 2017 Dec 4;7(1):16878. doi: 10.1038/s41598-017-17204-5.

37.

Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasms.

Fagunwa IO, Loughrey MB, Coleman HG.

Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):561-568. doi: 10.1016/j.bpg.2017.09.012. Epub 2017 Nov 11. Review.

PMID:
29195676
38.

Alcohol, smoking and the GI tract.

McCain S, Coleman HG.

Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):489. doi: 10.1016/j.bpg.2017.10.003. Epub 2017 Oct 12. No abstract available.

PMID:
29195667
39.

Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review.

Kunzmann AT, McMenamin ÚC, Spence AD, Gray RT, Murray LJ, Turkington RC, Coleman HG.

Eur J Gastroenterol Hepatol. 2018 Mar;30(3):263-273. doi: 10.1097/MEG.0000000000001029. Review.

PMID:
29189391
40.

Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.

Spence AD, Busby J, Johnston BT, Baron JA, Hughes CM, Coleman HG, Cardwell CR.

Gastroenterology. 2018 Mar;154(4):849-860.e1. doi: 10.1053/j.gastro.2017.10.044. Epub 2017 Nov 6.

PMID:
29122547
41.

IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer.

Hutchinson RA, Coleman HG, Gately K, Young V, Nicholson S, Cummins R, Kay E, Hynes SO, Dunne PD, Senevirathne S, Hamilton PW, McArt DG, Longley DB.

Cell Death Discov. 2017 Aug 14;3:17050. doi: 10.1038/cddiscovery.2017.50. eCollection 2017.

42.

The Epidemiology of Esophageal Adenocarcinoma.

Coleman HG, Xie SH, Lagergren J.

Gastroenterology. 2018 Jan;154(2):390-405. doi: 10.1053/j.gastro.2017.07.046. Epub 2017 Aug 3. Review.

PMID:
28780073
43.

Commonly used medications and endometrial cancer survival: a population-based cohort study.

Sanni OB, Mc Menamin ÚC, Cardwell CR, Sharp L, Murray LJ, Coleman HG.

Br J Cancer. 2017 Jul 25;117(3):432-438. doi: 10.1038/bjc.2017.207. Epub 2017 Jul 6.

44.

Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.

Shivappa N, Hebert JR, Anderson LA, Shrubsole MJ, Murray LJ, Getty LB, Coleman HG.

Br J Nutr. 2017 May;117(9):1323-1331. doi: 10.1017/S0007114517001131. Epub 2017 Jun 2.

PMID:
28571591
45.

Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.

Gray RT, Loughrey MB, Bankhead P, Cardwell CR, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ, Coleman HG.

Br J Cancer. 2017 Jun 6;116(12):1652-1659. doi: 10.1038/bjc.2017.139. Epub 2017 May 18.

46.

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study.

Gray RT, Cantwell MM, Coleman HG, Loughrey MB, Bankhead P, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, Cardwell CR, Johnston BT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ.

Clin Transl Gastroenterol. 2017 Apr 27;8(4):e91. doi: 10.1038/ctg.2017.18.

47.

Response to Park et al. reply to 'Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study'.

Hynes SO, Coleman HG, Kelly PJ, Dunne PD, Salto-Tellez M, Loughrey MB.

Histopathology. 2017 Aug;71(2):327-329. doi: 10.1111/his.13221. Epub 2017 May 19. No abstract available.

PMID:
28332733
48.

Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study.

Hynes SO, Coleman HG, Kelly PJ, Irwin S, O'Neill RF, Gray RT, McGready C, Dunne PD, McQuaid S, James JA, Salto-Tellez M, Loughrey MB.

Histopathology. 2017 Jul;71(1):12-26. doi: 10.1111/his.13181. Epub 2017 Apr 3.

PMID:
28165633
49.

Proceedings of the third international molecular pathological epidemiology (MPE) meeting.

Campbell PT, Rebbeck TR, Nishihara R, Beck AH, Begg CB, Bogdanov AA, Cao Y, Coleman HG, Freeman GJ, Heng YJ, Huttenhower C, Irizarry RA, Kip NS, Michor F, Nevo D, Peters U, Phipps AI, Poole EM, Qian ZR, Quackenbush J, Robins H, Rogan PK, Slattery ML, Smith-Warner SA, Song M, VanderWeele TJ, Xia D, Zabor EC, Zhang X, Wang M, Ogino S.

Cancer Causes Control. 2017 Feb;28(2):167-176. doi: 10.1007/s10552-016-0845-z. Epub 2017 Jan 17. Review.

50.

Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps.

Davenport JR, Su T, Zhao Z, Coleman HG, Smalley WE, Ness RM, Zheng W, Shrubsole MJ.

Gut. 2018 Mar;67(3):456-465. doi: 10.1136/gutjnl-2016-312893. Epub 2016 Nov 15.

Supplemental Content

Loading ...
Support Center